Abstract: A projection apparatus according to the present invention, includes: a field programmable gate array (FPGA) configured to control projection; and at least one processor which functions as: a configuration unit configured to configure a circuit to be included in the FPGA to a circuit corresponding to a state of the projection apparatus.

Abstract: An image display apparatus according to the present invention includes: a display unit configured to display a moving image based on input moving image data; a determining unit configured to determine whether or not a specific reproduction operation related to a reproduction method of the moving image data has been performed; and a control unit configured to control display by the display unit so that display of a moving image of which brightness is higher than a first threshold is suppressed in a case where the specific reproduction operation has been performed.

Abstract: A projection apparatus according to the present invention, includes: a field progranmable gate array (FPGA) configured to control projection; and at least one processor which functions as: a configuration unit configured to configure a circuit to be included in the FPGA to a circuit corresponding to a state of the projection apparatus.

Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Abstract: An information processing apparatus according to the present invention, includes: a first acquiring unit configured to acquire surface change information on magnitude of change of a projection surface onto which an image is projected; and a determining unit configured to determine, based on the surface change information, frame rate control information on a frame rate of image processing to allow the image to follow the projection surface.

Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Abstract: An object of the present invention is to provide a novel compound having a strong opening action with respect to KCNQ2-5 channels. A compound represented by the general formula (I) (wherein the definition of each group is as described in the specification) is provided. The compound represented by the general formula (I) has a strong opening action with respect to KCNQ2-5 channels, and therefore is useful as a prophylactic and/or therapeutic agent for a KCNQ2-5 channel-related disease (for example, dysuria, overactive bladder, or the like).

Abstract: An image processing apparatus according to the present invention, includes: a determination unit configured to determine, based on a layout of at least one image included in display image data, a display correspondence, which is a correspondence between a gradation value of the display image data and a display brightness in a case where a display unit displays an image based on the display image data; and an output unit configured to output to the display unit the display image data and information indicating the display correspondence.

Abstract: An image processing apparatus comprises: a first generation unit that generates approximate light pattern by adjusting spatial frequency of an input image, and generates a projection image data based on the approximate light pattern; and a second generation unit that generates a print image data based on the input image, wherein the second generation unit generates the print image data so that a difference between the input image and an image for observation obtained by superimposing projection light projected based on the projection image data onto a printed matter printed based on the print image data is reduced.

Abstract: Crystal polymorphism may exist in a crystalline compound. In the case where crystal polymorphism exists, depending on the crystal form, solubility, dissolution rate, stability against heat, light, humidity, etc. or the like is different. Accordingly, in the production of a pharmaceutical product, it is a very important task to select a crystal form of a drug substance most suitable for a disease indication and a dosage form. The present invention relates to novel crystal forms (A crystal, W crystal, and a hydrate crystal (H crystal)) of a compound I having a strong opening action with respect to KCNQ2-5 channels.

Abstract: An object of the present invention is to provide a novel compound having a strong opening action with respect to KCNQ2-5 channels. A compound represented by the general formula (1) (wherein the definition of each group is as described in the specification) is provided. The compound represented by the general formula (1) has a strong opening action with respect to KCNQ2-5 channels, and therefore is useful as a prophylactic and/or therapeutic agent for a KCNQ2-5 channel-related disease (for example, dysuria, overactive bladder, or the like).

Abstract: An information processing apparatus according to the present invention, includes: a first acquiring unit configured to acquire surface change information on magnitude of change of a projection surface onto which an image is projected; and a determining unit configured to determine, based on the surface change information, frame rate control information on a frame rate of image processing to allow the image to follow the projection surface.

Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Abstract: An image processing apparatus comprises: a first generation unit that generates approximate light pattern by adjusting spatial frequency of an input image, and generates a projection image data based on the approximate light pattern; and a second generation unit that generates a print image data based on the input image, wherein the second generation unit generates the print image data so that a difference between the input image and an image for observation obtained by superimposing projection light projected based on the projection image data onto a printed matter printed based on the print image data is reduced.

Abstract: The present invention relates to a compound represented by the general formula (I) (wherein the definition of each group has the same meaning as described in the specification). The compound is useful as preventive and/or therapeutic agent for KCNQ2-5 channel-related diseases.

Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.

Abstract: An image processing apparatus according to the present invention, includes: a determination unit configured to determine, based on a layout of at least one image included in display image data, a display correspondence, which is a correspondence between a gradation value of the display image data and a display brightness in a case where a display unit displays an image based on the display image data; and an output unit configured to output to the display unit the display image data and information indicating the display correspondence.

Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.

Abstract: An image display apparatus according to the present invention includes: a display unit configured to display a moving image based on input moving image data; a determining unit configured to determine whether or not a specific reproduction operation related to a reproduction method of the moving image data has been performed; and a control unit configured to control display by the display unit so that display of a moving image of which brightness is higher than a first threshold is suppressed in a case where the specific reproduction operation has been performed.